TrialLeukemia2007

Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.

D Tomizawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.